Accredited by Ministry of Health: 10 CME Credit points
CME Certification for International Diabetes Summit from Ministry of Health UAE:
This conference is accredited by Ministry of Health, UAE for 10 CME credit points. 4 Credit points will be issued to officials at the Day 1 and 6 Credit points will be issued to officials on the Day 2. The Lecturers may be given 3 Credit Hours, for delivering the lecture program and session's Chair Person would get 2.0 Credit Hours for chairing any session.
Diabetes is a global threat, researchers estimate that 366 million people, or 4.4% of the world’s population will be diabetic by 2030. Diabetes prevalence in some countries in the ME Region is among the highest in the world. Studies conducted in different populations have reported prevalence rates as high as 20% in the United Arab Emirates, 16% in Qatar and 15% in Bahrain.
Former United Nations Secretary-General Kofi Annan underlined the need for global action: “Across the world, the threat [of diabetes] is ignored and under-funded. Tackling diabetes must be a priority. It is so serious that we all have to be involved if we are to reverse this epidemic.” The human and economic costs of this epidemic are enormous, diabetes increases the risk for heart disease and other health problems, and therefore it is important to give this disease more attention.
The purpose of this forum is to bring together international experts from International health organizations, national health authorities, local diabetic associations, academics, and local, regional and global media to:
- Highlight the rising prevalence of diabetes and its complications in the world in general and in the middle east in particular
- Discuss the recent issues related to prevention, management and treatment of diabetes.
- Develop global and national strategies to reduce the socio-economic burden of diabetes.
- Create a network of committed global and regional key opinion leaders to exchange their knowledge and experiences and by this way contribute to overall improvement of patient care.
For speaking opportunities kindly contact: Doaa Said at
Doaa.said@fleminggulf.com
Key speakers:
- Prof. Tawfik Ahmed Khoja, Executive Director, Executive Board of the health ministries
- Dr. Abdulrahman Salem Alkuwari, President, Gulf Group for the Study of Diabetes, Qatar
- Dr. Abdulaziz Al Twaim, Vice president and King Abdulaziz Medical City, Section Head and Consultant Pediatric Endocrinologist, Saudi Pediatric Association
- Dr. Abdulmoein Al Agha, Consultant Pediatric Endocrinologist, King Abdulaziz University Hospital, KSA
- Dr. Nabil Naggar, Head of diabetes center, Hai Al Jamea Hospital, KSA
- Dr. Mariam E.A. Al Hajeri, Vice- President and Consultant Family Physician, Bahrain Diabetes Society, Bahrain
- Dr. Ibtihal Fadil, The Regional Office for The Eastern Mediterranean EMRO, Regional Advisor, World Health Organization (WHO)
- Dr. Mahmoud Fikri, CEO Health Policies Affairs and Chairman of National Diabetes Board, Ministry of Health UAE
- Dr. Belal Al Shammaa, Director, Consultant Endocrinologist, The American Hospital Dubai, Diabetes Center of Excellence, UAE
- Dr. Susan Tulley, Podiatrist, Tawam Hospital, UAE
- Ahmed Omer Hawsawi, Representative, Council of Nursing and Nursing Specialization for Cooperation Council States
- Dr. Surendra Ugale, Chief & Director of Laparoscopic Training Institute, Advanced Laparoscopy & Metabolic Surgery Center, Kirloskar Hospital, India
- Dr. Fatma H. AlMarashi, Medical Director, University Hospital - DHCC, UAE
- Dr. Almoutaz Alkheir Ahmed Abdulrhman, Diabetologist, Gurayat Diabetes Center, KSA
Our valued advisors:
- Dr. Abdulrahman Salem Alkuwari, President, Chairman of the Advisory Council, Gulf Group for the Study of Diabetes, Qatar
- Dr. Hassan Mziaut, Senior Scientist, Solimena Group, Germany
- Dr. Mohammed Kamal Mostafa, Representative, The Egyptian Medical Association for the Study of Obesity (EMASO), Egypt
- Dr. Jason Halford, Professor at the dept. of Psychology, University of Liverpool, UK
- Dr. Abdulmoein Al Agha, Consultant Pediatric Endocrinologist, King Abdulaziz University Hospital, KSA
- Prof. Saverio Cinti, Professor, Faculty of medicine Ancona, Italy
- Dr. Nabil Naggar, Head of diabetes center, Hai Al Jamea Hospital, KSA
Key topics:
- Global Impact of Diabetes
- Diabetes in Middle East – Challenges and Opportunities
- National strategies to reduce the socio economic burden of diabetes
- Clinical Diabetes
- Diabetes and Cardiovascular Risk management
- Juvenile Diabetes
- Foot care in Diabetes
- Nutrition in Diabetes
Who should attend:
Job Titles:
Heads and managers who are: Diabetologists, Psychologists, Endocrinologists, Internal medicine doctors, General practitioners, Healthcare professionals who manage the complications of patients with diabetes: e.g. Ophthalmologists, cardiologists, Podiatrics..... etc; Chief nurses, Chief pharmacists etc.
from Local Diabetic Associations; National Health Authorities; Hospital and medical clinics
Industries:
Diabetic care devices providers, Pharmaceutical companies providing Insulin and oral diabetic medicines, Bariatric Surgery providers etc.
Brochure Request
| Event info: T: +9181 0580 5411 F: +9180 4050 9933 E: lucia.kasanicka@fleminggulf.com |
Sponsorship info: T: +9197 3118 3803 F: +9180 4050 9933 E: john.paul@fleminggulf.com |
Sponsors
Platinum Sponsor:
Sanofi-aventis’ ambition is to become a diversified global healthcare leader, Focused on patients’ needs. The Group strategy is based on three key principles in order to deliver long-term sustainable growth: A) Increasing innovation in Research & Development; B) Seizing external growth opportunities; C) Adapting Group structures for future challenges.
Silver Sponsor:
We employ more than 44,000 people worldwide and market our medicines in 143 countries. Lilly has major research and development facilities in nine countries, with over 8,400 employees carrying out clinical research in more than 60 countries.
Associate Sponsor:
Exhibitors:
Western Healthcare Technology was founded in 2009 covering the United Arab Emirates representing ACON Diabetes Care, a Global leader in Blood Glucose Monitoring System. Creating awareness among the people and providing information to better manage Diabetes, with a highly competitive price and quality maintained products, it would be more convenient for valued customers who believe only in quality. The partnership aims to be the global leader in our industry based on consistent quality and execution, exceptional customer aligned services and constant innovation. We look forward in achieving our objectives and prime dream to be of service to the community by giving the most affordable quality service and supplies.
Project winner of the French National Award for innovating company creation, OTR3 was created in 2000 by Professors Jean-Pierre Caruelle and Denis Barritault. OTR3, for Organ, Tissue, Regeneration, Reparation, Replacement, conceives and develops active therapeutic agents, especially RGTA (ReGeneraTing Agent), and ensure their market availability. The aim is to bring new therapeutic solutions to the healthcare professionals, and comfort to the patients by promoting the research on the extracellular matrix and develop healing care products.
GSMS provides every health care facility in the region with the most advanced medical technology available globally making it accessible to the end user in need; direct its growth in the areas of medical engineering where we exhibit maximum strength and capability; to gather people and facilities that tend to enhance these areas and focus on sustain good citizenship as a corporation.
Strategic Partner:
Supporting Association:
Council of Nursing and Nursing Specialization for Cooperation Council States
Media Partners:
Pharma Voice Free Digital Subscription:
